More than 9,700 people have petitioned to ban a bladed tool used in laparoscopic hysterectomies after learning of serious injuries alleged in power morcellator lawsuit claims, according to an update recently posted on the petition’s website.

Change.org updated its website on June 13th to show that 9,745 people had signed a petition launched by a Massachusetts woman who was diagnosed with stage four leiomyosarcoma after undergoing a morcellator-aided procedure last October. She and her husband told CBS News Boston in April that new postings are added to the petition each day by women and their loved ones who claim to have been injured by a morcellator, which works by cutting up tissue so that it can be more easily removed through small abdominal incisions.

The problem allegedly lies though, in its potential to spread previously undiagnosed uterine sarcoma outside the uterus and into other areas of the abdominal cavity. This form of uterine cancer is difficult to detect and almost never discovered until after the fibroid removal procedure. According to a morcellator warning issued in April by the U.S. Food and Drug Administration (FDA), an estimated 1 in every 350 women who have fibroids removed have undetected uterine sarcoma cells in their fibroids. If the cancer spreads outside a woman’s uterus before it is removed and biopsied, her long-term rate of survival is likely to be severely diminished, according to the FDA.

FDA Plans to Discuss Alleged Power Morcellator Risks at July Meeting

As power morcellator lawsuits continue to be filed, the federal agency has announced its plans to discuss the issue further with its Obstetrics and Gynecological Devices Panel.  A 2-day conference has been scheduled to take place on July 10, where the Committee will discuss recommendations regarding the appropriate use of morcellators, as well as premarket device testing, labeling, and other matters related to side effects that may stem from use of the devices.

Following the FDA’s public alert in April, Johnson & Johnson announced that it would halt sales of morcellators marketed by its subsidiary, Ethicon Inc. pending further guidance from regulators. A uterine sarcoma lawsuit filed a month later in the U.S. District Court for the Northern District of California blamed one of the company’s devices in claims alleging the dissemination of uterine cancer cells.

Filing a Power Morcellator Lawsuit

If you underwent a laparoscopic hysterectomy or fibroid removal surgery that used a morcellator, the time is now to contact an attorney at our Firm for more information about your legal options. Call an attorney today at (877) 779-1414.

Published June 16, 2014 by